Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Beta Bionics, Inc. (BBNX) had Cost of Goods Sold of $13.11M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$32.01M |
|
$-23.40M |
|
|
Cost of Goods Sold |
$13.11M |
$18.90M |
|
$57.59M |
|
$-25.58M |
|
$2.17M |
|
$-23.40M |
|
$-23.40M |
|
$-23.40M |
|
$-23.40M |
|
$-23.40M |
|
$-23.40M |
|
$-25.58M |
|
$-24.28M |
|
44.55M |
|
44.55M |
|
$-0.53 |
|
$-0.53 |
|
| Balance Sheet Financials | |
$231.03M |
|
$10.75M |
|
$61.35M |
|
$292.39M |
|
$26.02M |
|
-- |
|
$10.00M |
|
$36.02M |
|
$256.37M |
|
$256.37M |
|
$256.37M |
|
44.98M |
|
| Cash Flow Statement Financials | |
$-38.45M |
|
$48.77M |
|
$2.42M |
|
$31.68M |
|
$44.42M |
|
$12.74M |
|
$12.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
59.04% |
|
-79.90% |
|
-79.90% |
|
-- |
|
-73.10% |
|
-73.10% |
|
$-40.87M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.55 |
|
1.77 |
|
50.75 |
|
-9.13% |
|
-9.13% |
|
-8.00% |
|
-9.13% |
|
$5.70 |
|
$-0.92 |
|
$-0.86 |
|